Global Predictive and Presymptomatic Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028
Predictive genetic testing searches for genetic changes, or mutations, that are linked to disease. These tests are done before you show any signs of a disease.
The Predictive and Presymptomatic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Predictive and Presymptomatic Testing market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Predictive and Presymptomatic Testing market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Breast and Ovarian Cancer occupied for % of the Predictive and Presymptomatic Testing global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Presymptomatic Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Predictive and Presymptomatic Testing include 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc. and Direct Laboratory Services LLC (DirectLabs), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Predictive and Presymptomatic Testing market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Predictive and Presymptomatic Testing companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Predictive and Presymptomatic Testing market based on the following parameters – headquarters, products portfolio, Predictive and Presymptomatic Testing revenue and gross margin, recent developments.
Evaluation and forecast the Predictive and Presymptomatic Testing market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Predictive and Presymptomatic Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
Chapter 1, to describe Predictive and Presymptomatic Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Predictive and Presymptomatic Testing, with revenue, gross margin and global market share of Predictive and Presymptomatic Testing from 2019 to 2022.
Chapter 3, the Predictive and Presymptomatic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Predictive and Presymptomatic Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Predictive and Presymptomatic Testing research findings and conclusion, appendix and data source.
The Predictive and Presymptomatic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 and Russia-Ukraine War influence, the global Predictive and Presymptomatic Testing market size was valued at USD million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period.
The Predictive and Presymptomatic Testing market in the USA. is estimated at USD million in 2022, which currently accounts for a % share in the global market. China, the world`s second largest economy, is estimated at USD million in 2022 and holds a % percent.
Breast and Ovarian Cancer occupied for % of the Predictive and Presymptomatic Testing global market in 2021, and it is projected to value USD million by 2028, growing at a % CAGR in next six years. In terms of product type, Presymptomatic Testing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Predictive and Presymptomatic Testing include 23andMe, Inc., Abbott Molecular, Inc., BioAxis DNA Research Centre Private Limited, Color Genomics, Inc. and Direct Laboratory Services LLC (DirectLabs), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Key Features of This Report:
This report provides in-depth analysis of the global Predictive and Presymptomatic Testing market, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year.
Main Predictive and Presymptomatic Testing companies’ industry ranking, revenue, and market share analysis. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This reports profiles key players in the global Predictive and Presymptomatic Testing market based on the following parameters – headquarters, products portfolio, Predictive and Presymptomatic Testing revenue and gross margin, recent developments.
Evaluation and forecast the Predictive and Presymptomatic Testing market size, projected growth trends, and corresponding market share analysis by type, by application and by region. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
Highlights of the current market scenario, recent information, latest developments, and factors impacting the growth of the market
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Market segmentation
Predictive and Presymptomatic Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of revenue. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type (2017-2028; USD Million)
- Presymptomatic Testing
- Predispositional Testing
- Breast and Ovarian Cancer
- Colorectal Cancer
- Alzheimer's Disease
- Multiple Endocrine Neoplasia Type 2
- Haemochromatosis
- 23andMe, Inc.
- Abbott Molecular, Inc.
- BioAxis DNA Research Centre Private Limited
- Color Genomics, Inc.
- Direct Laboratory Services LLC (DirectLabs)
- Gene by Gene Ltd.
- Genomic Diagnostics
- Mapmygenome
- Myriad Genetics, Inc.
- Pathway Genomics Corporation
- Positive Bioscience, Inc.
- Quest Diagnostics, Inc.
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Australia)
- South America (Brazil, Argentina, Colombia and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa and Rest of Middle East & Africa)
Chapter 1, to describe Predictive and Presymptomatic Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Predictive and Presymptomatic Testing, with revenue, gross margin and global market share of Predictive and Presymptomatic Testing from 2019 to 2022.
Chapter 3, the Predictive and Presymptomatic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Predictive and Presymptomatic Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Predictive and Presymptomatic Testing research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Predictive and Presymptomatic Testing
1.2 Classification of Predictive and Presymptomatic Testing by Type
1.2.1 Overview: Global Predictive and Presymptomatic Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Predictive and Presymptomatic Testing Revenue Market Share by Type in 2021
1.2.3 Presymptomatic Testing
1.2.4 Predispositional Testing
1.3 Global Predictive and Presymptomatic Testing Market by Application
1.3.1 Overview: Global Predictive and Presymptomatic Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast and Ovarian Cancer
1.3.3 Colorectal Cancer
1.3.4 Alzheimer's Disease
1.3.5 Multiple Endocrine Neoplasia Type
1.3.6 Haemochromatosis
1.4 Global Predictive and Presymptomatic Testing Market Size & Forecast
1.5 Global Predictive and Presymptomatic Testing Market Size and Forecast by Region
1.5.1 Global Predictive and Presymptomatic Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Predictive and Presymptomatic Testing Market Size by Region, (2017-2022)
1.5.3 North America Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.5.6 South America Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Predictive and Presymptomatic Testing Market Drivers
1.6.2 Predictive and Presymptomatic Testing Market Restraints
1.6.3 Predictive and Presymptomatic Testing Trends Analysis
2 COMPANY PROFILES
2.1 23andMe, Inc.
2.1.1 23andMe, Inc. Details
2.1.2 23andMe, Inc. Major Business
2.1.3 23andMe, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.1.4 23andMe, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 23andMe, Inc. Recent Developments and Future Plans
2.2 Abbott Molecular, Inc.
2.2.1 Abbott Molecular, Inc. Details
2.2.2 Abbott Molecular, Inc. Major Business
2.2.3 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.2.4 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Molecular, Inc. Recent Developments and Future Plans
2.3 BioAxis DNA Research Centre Private Limited
2.3.1 BioAxis DNA Research Centre Private Limited Details
2.3.2 BioAxis DNA Research Centre Private Limited Major Business
2.3.3 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product and Solutions
2.3.4 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 BioAxis DNA Research Centre Private Limited Recent Developments and Future Plans
2.4 Color Genomics, Inc.
2.4.1 Color Genomics, Inc. Details
2.4.2 Color Genomics, Inc. Major Business
2.4.3 Color Genomics, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.4.4 Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Color Genomics, Inc. Recent Developments and Future Plans
2.5 Direct Laboratory Services LLC (DirectLabs)
2.5.1 Direct Laboratory Services LLC (DirectLabs) Details
2.5.2 Direct Laboratory Services LLC (DirectLabs) Major Business
2.5.3 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product and Solutions
2.5.4 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Direct Laboratory Services LLC (DirectLabs) Recent Developments and Future Plans
2.6 Gene by Gene Ltd.
2.6.1 Gene by Gene Ltd. Details
2.6.2 Gene by Gene Ltd. Major Business
2.6.3 Gene by Gene Ltd. Predictive and Presymptomatic Testing Product and Solutions
2.6.4 Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Gene by Gene Ltd. Recent Developments and Future Plans
2.7 Genomic Diagnostics
2.7.1 Genomic Diagnostics Details
2.7.2 Genomic Diagnostics Major Business
2.7.3 Genomic Diagnostics Predictive and Presymptomatic Testing Product and Solutions
2.7.4 Genomic Diagnostics Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Genomic Diagnostics Recent Developments and Future Plans
2.8 Mapmygenome
2.8.1 Mapmygenome Details
2.8.2 Mapmygenome Major Business
2.8.3 Mapmygenome Predictive and Presymptomatic Testing Product and Solutions
2.8.4 Mapmygenome Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Mapmygenome Recent Developments and Future Plans
2.9 Myriad Genetics, Inc.
2.9.1 Myriad Genetics, Inc. Details
2.9.2 Myriad Genetics, Inc. Major Business
2.9.3 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.9.4 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.10 Pathway Genomics Corporation
2.10.1 Pathway Genomics Corporation Details
2.10.2 Pathway Genomics Corporation Major Business
2.10.3 Pathway Genomics Corporation Predictive and Presymptomatic Testing Product and Solutions
2.10.4 Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Pathway Genomics Corporation Recent Developments and Future Plans
2.11 Positive Bioscience, Inc.
2.11.1 Positive Bioscience, Inc. Details
2.11.2 Positive Bioscience, Inc. Major Business
2.11.3 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.11.4 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Positive Bioscience, Inc. Recent Developments and Future Plans
2.12 Quest Diagnostics, Inc.
2.12.1 Quest Diagnostics, Inc. Details
2.12.2 Quest Diagnostics, Inc. Major Business
2.12.3 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.12.4 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Quest Diagnostics, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Predictive and Presymptomatic Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Predictive and Presymptomatic Testing Players Market Share in 2021
3.2.2 Top 10 Predictive and Presymptomatic Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Predictive and Presymptomatic Testing Players Head Office, Products and Services Provided
3.4 Predictive and Presymptomatic Testing Mergers & Acquisitions
3.5 Predictive and Presymptomatic Testing New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Predictive and Presymptomatic Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Predictive and Presymptomatic Testing Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Predictive and Presymptomatic Testing Revenue Market Share by Application (2017-2022)
5.2 Global Predictive and Presymptomatic Testing Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
6.2 North America Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
6.3 North America Predictive and Presymptomatic Testing Market Size by Country
6.3.1 North America Predictive and Presymptomatic Testing Revenue by Country (2017-2028)
6.3.2 United States Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
7.2 Europe Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
7.3 Europe Predictive and Presymptomatic Testing Market Size by Country
7.3.1 Europe Predictive and Presymptomatic Testing Revenue by Country (2017-2028)
7.3.2 Germany Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7.3.3 France Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Predictive and Presymptomatic Testing Market Size by Region
8.3.1 Asia-Pacific Predictive and Presymptomatic Testing Revenue by Region (2017-2028)
8.3.2 China Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.5 India Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
9.2 South America Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
9.3 South America Predictive and Presymptomatic Testing Market Size by Country
9.3.1 South America Predictive and Presymptomatic Testing Revenue by Country (2017-2028)
9.3.2 Brazil Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Country
10.3.1 Middle East & Africa Predictive and Presymptomatic Testing Revenue by Country (2017-2028)
10.3.2 Turkey Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Product Overview and Scope of Predictive and Presymptomatic Testing
1.2 Classification of Predictive and Presymptomatic Testing by Type
1.2.1 Overview: Global Predictive and Presymptomatic Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Predictive and Presymptomatic Testing Revenue Market Share by Type in 2021
1.2.3 Presymptomatic Testing
1.2.4 Predispositional Testing
1.3 Global Predictive and Presymptomatic Testing Market by Application
1.3.1 Overview: Global Predictive and Presymptomatic Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast and Ovarian Cancer
1.3.3 Colorectal Cancer
1.3.4 Alzheimer's Disease
1.3.5 Multiple Endocrine Neoplasia Type
1.3.6 Haemochromatosis
1.4 Global Predictive and Presymptomatic Testing Market Size & Forecast
1.5 Global Predictive and Presymptomatic Testing Market Size and Forecast by Region
1.5.1 Global Predictive and Presymptomatic Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Predictive and Presymptomatic Testing Market Size by Region, (2017-2022)
1.5.3 North America Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.5.6 South America Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Predictive and Presymptomatic Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Predictive and Presymptomatic Testing Market Drivers
1.6.2 Predictive and Presymptomatic Testing Market Restraints
1.6.3 Predictive and Presymptomatic Testing Trends Analysis
2 COMPANY PROFILES
2.1 23andMe, Inc.
2.1.1 23andMe, Inc. Details
2.1.2 23andMe, Inc. Major Business
2.1.3 23andMe, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.1.4 23andMe, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 23andMe, Inc. Recent Developments and Future Plans
2.2 Abbott Molecular, Inc.
2.2.1 Abbott Molecular, Inc. Details
2.2.2 Abbott Molecular, Inc. Major Business
2.2.3 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.2.4 Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Abbott Molecular, Inc. Recent Developments and Future Plans
2.3 BioAxis DNA Research Centre Private Limited
2.3.1 BioAxis DNA Research Centre Private Limited Details
2.3.2 BioAxis DNA Research Centre Private Limited Major Business
2.3.3 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product and Solutions
2.3.4 BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 BioAxis DNA Research Centre Private Limited Recent Developments and Future Plans
2.4 Color Genomics, Inc.
2.4.1 Color Genomics, Inc. Details
2.4.2 Color Genomics, Inc. Major Business
2.4.3 Color Genomics, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.4.4 Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Color Genomics, Inc. Recent Developments and Future Plans
2.5 Direct Laboratory Services LLC (DirectLabs)
2.5.1 Direct Laboratory Services LLC (DirectLabs) Details
2.5.2 Direct Laboratory Services LLC (DirectLabs) Major Business
2.5.3 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product and Solutions
2.5.4 Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Direct Laboratory Services LLC (DirectLabs) Recent Developments and Future Plans
2.6 Gene by Gene Ltd.
2.6.1 Gene by Gene Ltd. Details
2.6.2 Gene by Gene Ltd. Major Business
2.6.3 Gene by Gene Ltd. Predictive and Presymptomatic Testing Product and Solutions
2.6.4 Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Gene by Gene Ltd. Recent Developments and Future Plans
2.7 Genomic Diagnostics
2.7.1 Genomic Diagnostics Details
2.7.2 Genomic Diagnostics Major Business
2.7.3 Genomic Diagnostics Predictive and Presymptomatic Testing Product and Solutions
2.7.4 Genomic Diagnostics Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Genomic Diagnostics Recent Developments and Future Plans
2.8 Mapmygenome
2.8.1 Mapmygenome Details
2.8.2 Mapmygenome Major Business
2.8.3 Mapmygenome Predictive and Presymptomatic Testing Product and Solutions
2.8.4 Mapmygenome Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Mapmygenome Recent Developments and Future Plans
2.9 Myriad Genetics, Inc.
2.9.1 Myriad Genetics, Inc. Details
2.9.2 Myriad Genetics, Inc. Major Business
2.9.3 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.9.4 Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Myriad Genetics, Inc. Recent Developments and Future Plans
2.10 Pathway Genomics Corporation
2.10.1 Pathway Genomics Corporation Details
2.10.2 Pathway Genomics Corporation Major Business
2.10.3 Pathway Genomics Corporation Predictive and Presymptomatic Testing Product and Solutions
2.10.4 Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Pathway Genomics Corporation Recent Developments and Future Plans
2.11 Positive Bioscience, Inc.
2.11.1 Positive Bioscience, Inc. Details
2.11.2 Positive Bioscience, Inc. Major Business
2.11.3 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.11.4 Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Positive Bioscience, Inc. Recent Developments and Future Plans
2.12 Quest Diagnostics, Inc.
2.12.1 Quest Diagnostics, Inc. Details
2.12.2 Quest Diagnostics, Inc. Major Business
2.12.3 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product and Solutions
2.12.4 Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Quest Diagnostics, Inc. Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Predictive and Presymptomatic Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Predictive and Presymptomatic Testing Players Market Share in 2021
3.2.2 Top 10 Predictive and Presymptomatic Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Predictive and Presymptomatic Testing Players Head Office, Products and Services Provided
3.4 Predictive and Presymptomatic Testing Mergers & Acquisitions
3.5 Predictive and Presymptomatic Testing New Entrants and Expansion Plans
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Predictive and Presymptomatic Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Predictive and Presymptomatic Testing Market Forecast by Type (2023-2028)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Predictive and Presymptomatic Testing Revenue Market Share by Application (2017-2022)
5.2 Global Predictive and Presymptomatic Testing Market Forecast by Application (2023-2028)
6 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
6.1 North America Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
6.2 North America Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
6.3 North America Predictive and Presymptomatic Testing Market Size by Country
6.3.1 North America Predictive and Presymptomatic Testing Revenue by Country (2017-2028)
6.3.2 United States Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION
7.1 Europe Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
7.2 Europe Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
7.3 Europe Predictive and Presymptomatic Testing Market Size by Country
7.3.1 Europe Predictive and Presymptomatic Testing Revenue by Country (2017-2028)
7.3.2 Germany Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7.3.3 France Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION
8.1 Asia-Pacific Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Predictive and Presymptomatic Testing Market Size by Region
8.3.1 Asia-Pacific Predictive and Presymptomatic Testing Revenue by Region (2017-2028)
8.3.2 China Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.5 India Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
9 SOUTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION
9.1 South America Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
9.2 South America Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
9.3 South America Predictive and Presymptomatic Testing Market Size by Country
9.3.1 South America Predictive and Presymptomatic Testing Revenue by Country (2017-2028)
9.3.2 Brazil Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
10 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION
10.1 Middle East & Africa Predictive and Presymptomatic Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Predictive and Presymptomatic Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Predictive and Presymptomatic Testing Market Size by Country
10.3.1 Middle East & Africa Predictive and Presymptomatic Testing Revenue by Country (2017-2028)
10.3.2 Turkey Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Predictive and Presymptomatic Testing Market Size and Forecast (2017-2028)
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. Global Predictive and Presymptomatic Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Predictive and Presymptomatic Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Predictive and Presymptomatic Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Predictive and Presymptomatic Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Predictive and Presymptomatic Testing Revenue Market Share by Region (2023-2028)
Table 6. 23andMe, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. 23andMe, Inc. Major Business
Table 8. 23andMe, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 9. 23andMe, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Molecular, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Molecular, Inc. Major Business
Table 12. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 13. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. BioAxis DNA Research Centre Private Limited Corporate Information, Head Office, and Major Competitors
Table 15. BioAxis DNA Research Centre Private Limited Major Business
Table 16. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product and Solutions
Table 17. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Color Genomics, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Color Genomics, Inc. Major Business
Table 20. Color Genomics, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 21. Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Direct Laboratory Services LLC (DirectLabs) Corporate Information, Head Office, and Major Competitors
Table 23. Direct Laboratory Services LLC (DirectLabs) Major Business
Table 24. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product and Solutions
Table 25. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Gene by Gene Ltd. Corporate Information, Head Office, and Major Competitors
Table 27. Gene by Gene Ltd. Major Business
Table 28. Gene by Gene Ltd. Predictive and Presymptomatic Testing Product and Solutions
Table 29. Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Genomic Diagnostics Corporate Information, Head Office, and Major Competitors
Table 31. Genomic Diagnostics Major Business
Table 32. Genomic Diagnostics Predictive and Presymptomatic Testing Product and Solutions
Table 33. Genomic Diagnostics Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Mapmygenome Corporate Information, Head Office, and Major Competitors
Table 35. Mapmygenome Major Business
Table 36. Mapmygenome Predictive and Presymptomatic Testing Product and Solutions
Table 37. Mapmygenome Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Myriad Genetics, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Myriad Genetics, Inc. Major Business
Table 40. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 41. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Pathway Genomics Corporation Corporate Information, Head Office, and Major Competitors
Table 43. Pathway Genomics Corporation Major Business
Table 44. Pathway Genomics Corporation Predictive and Presymptomatic Testing Product and Solutions
Table 45. Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Positive Bioscience, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Positive Bioscience, Inc. Major Business
Table 48. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 49. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Quest Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Quest Diagnostics, Inc. Major Business
Table 52. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 53. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Predictive and Presymptomatic Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Predictive and Presymptomatic Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Predictive and Presymptomatic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Predictive and Presymptomatic Testing Players Head Office, Products and Services Provided
Table 58. Predictive and Presymptomatic Testing Mergers & Acquisitions in the Past Five Years
Table 59. Predictive and Presymptomatic Testing New Entrants and Expansion Plans
Table 60. Global Predictive and Presymptomatic Testing Revenue (USD Million) by Type (2017-2022)
Table 61. Global Predictive and Presymptomatic Testing Revenue Share by Type (2017-2022)
Table 62. Global Predictive and Presymptomatic Testing Revenue Forecast by Type (2023-2028)
Table 63. Global Predictive and Presymptomatic Testing Revenue by Application (2017-2022)
Table 64. Global Predictive and Presymptomatic Testing Revenue Forecast by Application (2023-2028)
Table 65. North America Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Predictive and Presymptomatic Testing Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Predictive and Presymptomatic Testing Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Predictive and Presymptomatic Testing Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Predictive and Presymptomatic Testing Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Predictive and Presymptomatic Testing Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Predictive and Presymptomatic Testing Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Country (2023-2028) & (USD Million)
Table 1. Global Predictive and Presymptomatic Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Predictive and Presymptomatic Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Predictive and Presymptomatic Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Predictive and Presymptomatic Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Predictive and Presymptomatic Testing Revenue Market Share by Region (2023-2028)
Table 6. 23andMe, Inc. Corporate Information, Head Office, and Major Competitors
Table 7. 23andMe, Inc. Major Business
Table 8. 23andMe, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 9. 23andMe, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Abbott Molecular, Inc. Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Molecular, Inc. Major Business
Table 12. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 13. Abbott Molecular, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. BioAxis DNA Research Centre Private Limited Corporate Information, Head Office, and Major Competitors
Table 15. BioAxis DNA Research Centre Private Limited Major Business
Table 16. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Product and Solutions
Table 17. BioAxis DNA Research Centre Private Limited Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Color Genomics, Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Color Genomics, Inc. Major Business
Table 20. Color Genomics, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 21. Color Genomics, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Direct Laboratory Services LLC (DirectLabs) Corporate Information, Head Office, and Major Competitors
Table 23. Direct Laboratory Services LLC (DirectLabs) Major Business
Table 24. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Product and Solutions
Table 25. Direct Laboratory Services LLC (DirectLabs) Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Gene by Gene Ltd. Corporate Information, Head Office, and Major Competitors
Table 27. Gene by Gene Ltd. Major Business
Table 28. Gene by Gene Ltd. Predictive and Presymptomatic Testing Product and Solutions
Table 29. Gene by Gene Ltd. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Genomic Diagnostics Corporate Information, Head Office, and Major Competitors
Table 31. Genomic Diagnostics Major Business
Table 32. Genomic Diagnostics Predictive and Presymptomatic Testing Product and Solutions
Table 33. Genomic Diagnostics Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Mapmygenome Corporate Information, Head Office, and Major Competitors
Table 35. Mapmygenome Major Business
Table 36. Mapmygenome Predictive and Presymptomatic Testing Product and Solutions
Table 37. Mapmygenome Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Myriad Genetics, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Myriad Genetics, Inc. Major Business
Table 40. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 41. Myriad Genetics, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Pathway Genomics Corporation Corporate Information, Head Office, and Major Competitors
Table 43. Pathway Genomics Corporation Major Business
Table 44. Pathway Genomics Corporation Predictive and Presymptomatic Testing Product and Solutions
Table 45. Pathway Genomics Corporation Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Positive Bioscience, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. Positive Bioscience, Inc. Major Business
Table 48. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 49. Positive Bioscience, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Quest Diagnostics, Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Quest Diagnostics, Inc. Major Business
Table 52. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Product and Solutions
Table 53. Quest Diagnostics, Inc. Predictive and Presymptomatic Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Predictive and Presymptomatic Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Predictive and Presymptomatic Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Predictive and Presymptomatic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Predictive and Presymptomatic Testing Players Head Office, Products and Services Provided
Table 58. Predictive and Presymptomatic Testing Mergers & Acquisitions in the Past Five Years
Table 59. Predictive and Presymptomatic Testing New Entrants and Expansion Plans
Table 60. Global Predictive and Presymptomatic Testing Revenue (USD Million) by Type (2017-2022)
Table 61. Global Predictive and Presymptomatic Testing Revenue Share by Type (2017-2022)
Table 62. Global Predictive and Presymptomatic Testing Revenue Forecast by Type (2023-2028)
Table 63. Global Predictive and Presymptomatic Testing Revenue by Application (2017-2022)
Table 64. Global Predictive and Presymptomatic Testing Revenue Forecast by Application (2023-2028)
Table 65. North America Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Predictive and Presymptomatic Testing Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Predictive and Presymptomatic Testing Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Predictive and Presymptomatic Testing Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Predictive and Presymptomatic Testing Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Predictive and Presymptomatic Testing Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Predictive and Presymptomatic Testing Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Predictive and Presymptomatic Testing Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Predictive and Presymptomatic Testing Revenue by Country (2023-2028) & (USD Million)
LIST OF FIGURES
Figure 1. Predictive and Presymptomatic Testing Picture
Figure 2. Global Predictive and Presymptomatic Testing Revenue Market Share by Type in 2021
Figure 3. Presymptomatic Testing
Figure 4. Predispositional Testing
Figure 5. Predictive and Presymptomatic Testing Revenue Market Share by Application in 2021
Figure 6. Breast and Ovarian Cancer Picture
Figure 7. Colorectal Cancer Picture
Figure 8. Alzheimer's Disease Picture
Figure 9. Multiple Endocrine Neoplasia Type 2 Picture
Figure 10. Haemochromatosis Picture
Figure 11. Global Predictive and Presymptomatic Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Predictive and Presymptomatic Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Predictive and Presymptomatic Testing Revenue Market Share by Region (2017-2028)
Figure 14. Global Predictive and Presymptomatic Testing Revenue Market Share by Region in 2021
Figure 15. North America Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Predictive and Presymptomatic Testing Market Drivers
Figure 21. Predictive and Presymptomatic Testing Market Restraints
Figure 22. Predictive and Presymptomatic Testing Market Trends
Figure 23. 23andMe, Inc. Recent Developments and Future Plans
Figure 24. Abbott Molecular, Inc. Recent Developments and Future Plans
Figure 25. BioAxis DNA Research Centre Private Limited Recent Developments and Future Plans
Figure 26. Color Genomics, Inc. Recent Developments and Future Plans
Figure 27. Direct Laboratory Services LLC (DirectLabs) Recent Developments and Future Plans
Figure 28. Gene by Gene Ltd. Recent Developments and Future Plans
Figure 29. Genomic Diagnostics Recent Developments and Future Plans
Figure 30. Mapmygenome Recent Developments and Future Plans
Figure 31. Myriad Genetics, Inc. Recent Developments and Future Plans
Figure 32. Pathway Genomics Corporation Recent Developments and Future Plans
Figure 33. Positive Bioscience, Inc. Recent Developments and Future Plans
Figure 34. Quest Diagnostics, Inc. Recent Developments and Future Plans
Figure 35. Global Predictive and Presymptomatic Testing Revenue Share by Players in 2021
Figure 36. Predictive and Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Predictive and Presymptomatic Testing Revenue Market Share in 2021
Figure 38. Global Top 10 Players Predictive and Presymptomatic Testing Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Predictive and Presymptomatic Testing Revenue Share by Type in 2021
Figure 41. Global Predictive and Presymptomatic Testing Market Share Forecast by Type (2023-2028)
Figure 42. Global Predictive and Presymptomatic Testing Revenue Share by Application in 2021
Figure 43. Global Predictive and Presymptomatic Testing Market Share Forecast by Application (2023-2028)
Figure 44. North America Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 45. North America Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 46. North America Predictive and Presymptomatic Testing Revenue Market Share by Country (2017-2028)
Figure 47. United States Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 51. Europe Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 52. Europe Predictive and Presymptomatic Testing Revenue Market Share by Country (2017-2028)
Figure 53. Germany Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Predictive and Presymptomatic Testing Revenue Market Share by Region (2017-2028)
Figure 61. China Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 68. South America Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 69. South America Predictive and Presymptomatic Testing Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Predictive and Presymptomatic Testing Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Figure 1. Predictive and Presymptomatic Testing Picture
Figure 2. Global Predictive and Presymptomatic Testing Revenue Market Share by Type in 2021
Figure 3. Presymptomatic Testing
Figure 4. Predispositional Testing
Figure 5. Predictive and Presymptomatic Testing Revenue Market Share by Application in 2021
Figure 6. Breast and Ovarian Cancer Picture
Figure 7. Colorectal Cancer Picture
Figure 8. Alzheimer's Disease Picture
Figure 9. Multiple Endocrine Neoplasia Type 2 Picture
Figure 10. Haemochromatosis Picture
Figure 11. Global Predictive and Presymptomatic Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Predictive and Presymptomatic Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Predictive and Presymptomatic Testing Revenue Market Share by Region (2017-2028)
Figure 14. Global Predictive and Presymptomatic Testing Revenue Market Share by Region in 2021
Figure 15. North America Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Predictive and Presymptomatic Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Predictive and Presymptomatic Testing Market Drivers
Figure 21. Predictive and Presymptomatic Testing Market Restraints
Figure 22. Predictive and Presymptomatic Testing Market Trends
Figure 23. 23andMe, Inc. Recent Developments and Future Plans
Figure 24. Abbott Molecular, Inc. Recent Developments and Future Plans
Figure 25. BioAxis DNA Research Centre Private Limited Recent Developments and Future Plans
Figure 26. Color Genomics, Inc. Recent Developments and Future Plans
Figure 27. Direct Laboratory Services LLC (DirectLabs) Recent Developments and Future Plans
Figure 28. Gene by Gene Ltd. Recent Developments and Future Plans
Figure 29. Genomic Diagnostics Recent Developments and Future Plans
Figure 30. Mapmygenome Recent Developments and Future Plans
Figure 31. Myriad Genetics, Inc. Recent Developments and Future Plans
Figure 32. Pathway Genomics Corporation Recent Developments and Future Plans
Figure 33. Positive Bioscience, Inc. Recent Developments and Future Plans
Figure 34. Quest Diagnostics, Inc. Recent Developments and Future Plans
Figure 35. Global Predictive and Presymptomatic Testing Revenue Share by Players in 2021
Figure 36. Predictive and Presymptomatic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Predictive and Presymptomatic Testing Revenue Market Share in 2021
Figure 38. Global Top 10 Players Predictive and Presymptomatic Testing Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Predictive and Presymptomatic Testing Revenue Share by Type in 2021
Figure 41. Global Predictive and Presymptomatic Testing Market Share Forecast by Type (2023-2028)
Figure 42. Global Predictive and Presymptomatic Testing Revenue Share by Application in 2021
Figure 43. Global Predictive and Presymptomatic Testing Market Share Forecast by Application (2023-2028)
Figure 44. North America Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 45. North America Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 46. North America Predictive and Presymptomatic Testing Revenue Market Share by Country (2017-2028)
Figure 47. United States Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 51. Europe Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 52. Europe Predictive and Presymptomatic Testing Revenue Market Share by Country (2017-2028)
Figure 53. Germany Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Predictive and Presymptomatic Testing Revenue Market Share by Region (2017-2028)
Figure 61. China Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 68. South America Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 69. South America Predictive and Presymptomatic Testing Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Predictive and Presymptomatic Testing Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Predictive and Presymptomatic Testing Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Predictive and Presymptomatic Testing Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Predictive and Presymptomatic Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
